共 68 条
[1]
Brisse E(2015)Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders Cytokine Growth Factor Rev 26 263-280
[2]
Wouters CH(2011)Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol Blood 118 4577-4584
[3]
Matthys P(2015)Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis Am J Hematol 90 220-224
[4]
Trottestam H(2007)HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124-131
[5]
Horne A(2011)Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature Hematol Oncol 29 100-106
[6]
Arico M(2013)Hemophagocytic lymphohistiocytosis (HLH): a review of literature Med Oncol (Northwood, London, England) 30 740-159
[7]
Egeler RM(2015)Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies Annu Rev Med 66 145-492
[8]
Filipovich AH(2014)Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis Mayo Clin Proc 89 484-5157
[9]
Gadner H(2013)Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy Blood 121 5154-281
[10]
Otrock ZK(2016)Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial Crit Care Med 44 275-419